AAAAAA

   
Results: 1-14 |
Results: 14
Anatomic and biochemical correlates of the dopamine transporter ligand C-11-PE2I in normal and parkinsonian primates: Comparison with 6-[F-18] Fluoro-L-Dopa
Authors: Poyot, T Conde, F Gregoire, MC Frouin, V Coulon, C Fuseau, C Hinnen, F Dolle, F Hantraye, P Bottlaender, M
Citation: T. Poyot et al., Anatomic and biochemical correlates of the dopamine transporter ligand C-11-PE2I in normal and parkinsonian primates: Comparison with 6-[F-18] Fluoro-L-Dopa, J CEREBR B, 21(7), 2001, pp. 782-792
Perceptions about risk for HIV/AIDS among adolescents in juvenile detention
Authors: Anderson, NLR Nyamathi, A McAvoy, JA Conde, F Casey, C
Citation: Nlr. Anderson et al., Perceptions about risk for HIV/AIDS among adolescents in juvenile detention, W J NURS R, 23(4), 2001, pp. 336-359
A phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease
Authors: Berenson, JR Vescio, R Henick, K Nishikubo, C Rettig, M Swift, RA Conde, F Von Teichert, JM
Citation: Jr. Berenson et al., A phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease, CANCER, 91(1), 2001, pp. 144-154
A phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease
Authors: Berenson, JR Vescio, R Henick, K Nishikubo, C Rettig, M Swift, RA Conde, F Von Teichert, JM
Citation: Jr. Berenson et al., A phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease, CANC CYTOP, 91(1), 2001, pp. 144-154
Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease
Authors: Mittoux, V Joseph, JM Conde, F Palfi, S Dautry, C Poyot, T Bloch, J Deglon, N Ouary, S Nimchinsky, EA Brouillet, E Hof, PR Peschanski, M Aebischer, P Hantraye, P
Citation: V. Mittoux et al., Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease, HUM GENE TH, 11(8), 2000, pp. 1177-1187
Major strain differences in response to chronic systemic administration ofthe mitochondrial toxin 3-nitropropionic acid in rats: Implications for neuroprotection studies
Authors: Ouary, S Bizat, N Altairac, S Menetrat, H Mittoux, V Conde, F Hantraye, P Brouillet, E
Citation: S. Ouary et al., Major strain differences in response to chronic systemic administration ofthe mitochondrial toxin 3-nitropropionic acid in rats: Implications for neuroprotection studies, NEUROSCIENC, 97(3), 2000, pp. 521-530
Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid
Authors: Dautry, W Vaufrey, F Brouillet, E Bizat, N Henry, PG Conde, F Bloch, G Hantraye, P
Citation: W. Dautry et al., Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid, J CEREBR B, 20(5), 2000, pp. 789-799
Growth seasonality, photosynthetic pigments, and carbon and nitrogen content in relation to environmental factors: a field study of Ulva olivascens (Ulvales, Chlorophyta)
Authors: Altamirano, M Flores-Moya, A Conde, F Figueroa, FL
Citation: M. Altamirano et al., Growth seasonality, photosynthetic pigments, and carbon and nitrogen content in relation to environmental factors: a field study of Ulva olivascens (Ulvales, Chlorophyta), PHYCOLOGIA, 39(1), 2000, pp. 50-58
Replicating Huntington disease's phenotype in nonhuman primates
Authors: Hantraye, P Palfi, S Mittoux, V Dautry, C Conde, F Brouillet, E
Citation: P. Hantraye et al., Replicating Huntington disease's phenotype in nonhuman primates, CONT NEUROS, 2000, pp. 333-353
Serial 1H-NMR spectroscopy study of metabolic impairment in primates chronically treated with the succinate dehydrogenase inhibitor 3-nitropropionic acid
Authors: Dautry, C Conde, F Brouillet, E Mittoux, V Beal, MF Bloch, G Hantraye, P
Citation: C. Dautry et al., Serial 1H-NMR spectroscopy study of metabolic impairment in primates chronically treated with the succinate dehydrogenase inhibitor 3-nitropropionic acid, NEUROBIOL D, 6(4), 1999, pp. 259-268
Influence of the deposition parameters on La-A-Mn-O (A = Ca, Sr) films grown by low-pressure aerosol pyrolysis
Authors: Herrero, E Cabanas, MV Alonso, J Conde, F Gonzalez-Calbet, JM Vallet-Regi, M
Citation: E. Herrero et al., Influence of the deposition parameters on La-A-Mn-O (A = Ca, Sr) films grown by low-pressure aerosol pyrolysis, CHEM MATER, 11(12), 1999, pp. 3521-3527
Cellular distribution of the calcium binding proteins parvalbumin, calbindin, and calretinin in the neocortex of mammals: phylogenetic and developmental patterns
Authors: Hof, PR Glezer, II Conde, F Flagg, RA Rubin, MB Nimchinsky, EA Weisenhorn, DMV
Citation: Pr. Hof et al., Cellular distribution of the calcium binding proteins parvalbumin, calbindin, and calretinin in the neocortex of mammals: phylogenetic and developmental patterns, J CHEM NEUR, 16(2), 1999, pp. 77-116
Replicating Huntington's disease phenotype in experimental animals
Authors: Brouillet, E Conde, F Beal, MF Hantraye, P
Citation: E. Brouillet et al., Replicating Huntington's disease phenotype in experimental animals, PROG NEUROB, 59(5), 1999, pp. 427-468
New collections of benthic marine algae from Livingston and Deception Islands (South Shetland Islands) and Trinity Island (Bransfield Strait) Antarctica
Authors: Gallardo, T Perez-Ruzafa, IM Flores-Moya, A Conde, F
Citation: T. Gallardo et al., New collections of benthic marine algae from Livingston and Deception Islands (South Shetland Islands) and Trinity Island (Bransfield Strait) Antarctica, BOTAN MARIN, 42(1), 1999, pp. 61-69
Risultati: 1-14 |